Combination treatment of dipeptidyl peptidase IV inhibitor and angiotensin-II type 1 receptor blocker attenuates progression of nonalcoholic steatohepatitis in rats

被引：0
|
作者：
Okura, Yasushi [1 ]
Namisaki, Tadashi [1 ]
Kaji, Kosuke [1 ]
Noguchi, Ryuichi [1 ]
Takeda, Kosuke [1 ]
Moriya, Kei [1 ]
Kitade, Mitsuteru [1 ]
Nishimura, Norihisa [1 ]
Seki, Kenichiro [1 ]
Sato, Shinya [1 ]
Takaya, Hiroaki [1 ]
Kawaratani, Hideto [1 ]
Sawada, Yasuhiko [1 ]
Shimozato, Naotaka [1 ]
Nakanishi, Keisuke [1 ]
Yoshiji, Hitoshi [1 ]
机构：
[1] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1610
引用
收藏
页码：798A / 798A
页数：1
相关论文
共 50 条
  • [41] Effects of angiotensin-converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats
    Zhang, RY
    Wang, LF
    Zhang, L
    Meng, XN
    Li, SJ
    Wang, WR
    CHINESE MEDICAL JOURNAL, 2006, 119 (08) : 649 - 655
  • [42] Angiotensin II type 1 receptor blocker attenuates cell growth in vitro and in vivo
    Yu, C. C.
    Su, H. T.
    Chen, C. H.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 54 - 54
  • [43] Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease. Results of COOPERATE
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (09) : 76 - 76
  • [44] The Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril and the Angiotensin II Type 1 Receptor Blocker Losartan on Fracture Healing in Rats
    Bayar, Ahmet
    Turan, Ali
    Gulle, Kanat
    Akpolat, Meryem
    Turan, Inci
    Turhan, Egemen
    CLINICAL AND INVESTIGATIVE MEDICINE, 2015, 38 (04): : E164 - E172
  • [45] Dual therapy with acyclic retinoid and angiotensin-II receptor1 blocker attenuates chemically induced hepatocarcinogenesis in diabetic OLETF rats
    Nishimura, Norihisa
    Sato, Shinya
    Kaji, Kosuke
    Kitade, Mitsuteru
    Moriya, Kei
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2016, 64 : 233A - 234A
  • [46] ONTOGENY OF THE 2 ANGIOTENSIN-II TYPE-1 RECEPTOR SUBTYPES IN RATS
    SHANMUGAM, S
    CORVOL, P
    GASC, JM
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (06): : E828 - E836
  • [47] Beneficial effect of Angiotensin-II type 1 receptor blocker antihypertensive treatment on arterial stiffness. The role of smoking
    Kyvelou, Stella-Maria
    Vyssoulis, Gregory
    Karpanou, Eva
    Adamopoulos, Dionyssis
    Vlachopoulos, Charalambos
    Antonakoudis, George
    Pietri, Panagiota
    Cokkinos, Dennis
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 413A - 414A
  • [48] The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats
    Rahman, Asadur
    Sherajee, Shamshad J.
    Rafiq, Kazi
    Kobara, Hideki
    Masaki, Tsutomu
    Nakano, Daisuke
    Morikawa, Takashi
    Konishi, Yoshio
    Imanishi, Masahito
    Nishiyama, Akira
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 142 (03) : 124 - 126
  • [49] Angiotensin II type 1 receptor blocker combined with hydrochlorothiazide for the treatment of hypertension
    Miura, Shin-ichiro
    Saku, Keijiro
    INTERNAL MEDICINE, 2008, 47 (13) : 1163 - 1164
  • [50] Dipeptidyl Peptidase Inhibitor Linagliptin-and Angiotensin II Receptor Blocker Telmisartan-Induced Effects on Renal and Urinary Exosomal miRNA Expression in Rats with 5/6 Nephrectomy
    Delic, Denis
    Sontheimer, Kathrin
    Tsuprykov, Oleg
    Hasan, Ahmed A.
    Hocher, Berthold
    Baum, Patrick
    Kohler, Andreas
    Gantner, Florian
    Mark, Michael
    Klein, Thomas
    DIABETES, 2017, 66 : A131 - A131
12345